Health4 years ago
Indian Company Allowed To Market Biologic Therapy For COVID-19 Patients
India’s Biocon has received approval from the country’s drug regulator to market, Itolizumab injection, to treat cytokine release syndrome (CRS) in moderate to severe acute respiratory...
